ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,713.64
      1.70%
      US Tech 100
      19,318.00
      2.44%
      Dow Jones
      42,025.19
      1.26%
      Brent Oil
      74.32
      2.68%
      Bitcoin
      62,913.28
      1.99%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Revolution Medicines Inc (RVMD) Quote

      Revolution Medicines Inc

      Revolution Medicines Inc (RVMD)

      NASDAQ
      46.18
      2.12
      (4.81%)
      At close: September 19 4:00PM
      Delayed by 15 minutes
      46.18
      0.00
      ( 0.00% )
      After Hours: 4:00PM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      46.18
      Bid
      43.09
      Ask
      48.00
      Volume
      1,269,505
      44.51 Day's Range 46.60
      15.4401 52 Week Range 48.61
      Market Cap
      7.714B
      Previous Close
      44.06
      Open
      45.42
      Last Trade
      515
      @
      45.450583
      (average)
      Last Trade Time
      16:36:51
      Financial Volume
      $ 58,077,326
      VWAP
      45.748
      Average Volume (3m)
      1,333,616
      Shares Outstanding
      167,038,943
      Dividend Yield
      -
      PE Ratio
      -0.04
      Earnings Per Share (EPS)
      -2.61
      Revenue
      11.58M
      Net Profit
      -436.37M

      About Revolution Medicines Inc

      Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products include R... Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products include RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs. Show more

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Biological Pds,ex Diagnstics
      Website
      www.revmed.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Revolution Medicines Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker RVMD. The last closing price for Revolution Medicines was $44.06. Over the last year, Revolution Medicines shares have traded in a share price range of $ 15.4401 to $ 48.61.

      Revolution Medicines currently has 167,038,943 shares outstanding. The market capitalization of Revolution Medicines is $7.36 billion. Revolution Medicines has a price to earnings ratio (PE ratio) of -0.04.

      Ask ADVFN Intelligence (AI)

      Revolution Medicines (RVMD) Options Flow Summary

      RVMD Options Flow

      Overall Flow

      Bearish

      Net Premium

      -682k

      Calls / Puts

      9.52%

      Buys / Sells

      0.00%

      OTM / ITM

      4.55%

      Sweeps Ratio

      0.00%

      RVMD Latest News

      More News

      Form 4 - Statement of changes in beneficial ownership of securities

      August 23 2024
      Edgar (US Regulatory)

      Form 144 - Report of proposed sale of securities

      August 21 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      August 07 2024
      Edgar (US Regulatory)

      Form 3 - Initial statement of beneficial ownership of securities

      August 07 2024
      Edgar (US Regulatory)

      Form 424B5 - Prospectus [Rule 424(b)(5)]

      August 07 2024
      Edgar (US Regulatory)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      August 07 2024
      Edgar (US Regulatory)

      Revolution Medicines Reports Second Quarter 2024 Financial Results and Update on Corporate Progress

      REDWOOD CITY, Calif., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted...

      August 07 2024
      GlobeNewswire Inc.

      Form 8-K - Current report

      August 07 2024
      Edgar (US Regulatory)

      Revolution Medicines to Report Financial Results for Second Quarter 2024 After Market Close on August 7, 2024

      REDWOOD CITY, Calif., July 31, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted...

      July 31 2024
      GlobeNewswire Inc.

      Form 8-K - Current report

      July 15 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      14.029.5351043643342.1646.1841.55589542643.6520268CS
      40.912.0101612546945.2746.1840.869894742.94017728CS
      127.7320.104031209438.4548.6136.5133361643.70219917CS
      2615.450.03248862930.7848.6129.74129167939.98973939CS
      5215.5650.816459830230.6248.6115.4401166253631.56536569CS
      15615.5350.668841761830.6548.6114.08113825327.76431895CS
      26016.8357.342419080129.3556.1814.0890912729.03667196CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      LFLYLeafly Holdings Inc
      $ 3.78
      (111.17%)
      		4.68M
      AENTAlliance Entertainment Holding Corporation
      $ 2.80
      (37.25%)
      		122.42k
      TNONTenon Medical Inc
      $ 6.45
      (28.23%)
      		2.7M
      AEMDAethlon Medical Inc
      $ 0.4949
      (26.90%)
      		8.43M
      LDTCLeddarTech Holdings Inc
      $ 0.3649
      (22.45%)
      		180.12k
      EJHE Home Household Service Holdings Ltd
      $ 0.077
      (-21.11%)
      		8.68M
      KOPNKopin Corporation
      $ 0.8004
      (-16.98%)
      		191.23k
      NCINeo Concept International Group Holdings Ltd
      $ 0.74
      (-11.90%)
      		1.57M
      RZLVRezolve AI Ltd
      $ 6.3022
      (-9.97%)
      		40.17k
      ARQArq Inc
      $ 5.58
      (-9.56%)
      		87.77k
      EJHE Home Household Service Holdings Ltd
      $ 0.077
      (-21.11%)
      		8.68M
      AEMDAethlon Medical Inc
      $ 0.50
      (28.21%)
      		8.43M
      HSTHost Hotels and Resorts Inc
      $ 18.53
      (0.00%)
      		6.45M
      LFLYLeafly Holdings Inc
      $ 3.78
      (111.17%)
      		4.68M
      SQQQProShares UltraPro Short QQQ
      $ 7.79
      (0.39%)
      		4.62M

      RVMD Discussion

      View Posts
      axelvento axelvento 5 months ago
      Dr Olive added: 'I’ve been working on pancreatic cancer for almost 20 years, and I’ve never seen preclinical results like these.

      'I think there is a real chance this approach will help change the standard of care for pancreatic cancer patients, but only clinical trials can determine that
      👍️0
      axelvento axelvento 5 months ago
      Breakthrough in fight against world's deadliest cancer - new drug shrunk up to 70% of pancreatic tumors in lab study

      https://www.dailymail.co.uk/health/article-13284461/pancreatic-cancer-breakthrough-deadliest-disease-study.html
      👍️0
      Monksdream Monksdream 5 months ago
      RVMD over $30
      👍️0
      Monksdream Monksdream 7 months ago
      RVMD 10Q. 2/26
      👍️0

      Your Recent History

      NASDAQ
      RVMD
      Revolution Medicines
      Delayed Upgrade Clock